MDxHealth SA finalized a registered direct placement of more than 44 million ordinary shares. The transaction generated $20 million in gross proceeds. Management expects this capital to fund operations for at least the next 12 months.
The company cautioned that ongoing losses raise substantial doubt about its ability to continue as a going concern. This announcement follows a notification from Nasdaq regarding the company's share price. MDxHealth shares traded below the $1.00 minimum bid price for 30 consecutive business days.
For the six-month period ending June 30, 2026, the company reported $51.1 million in revenue. Net losses from continuing operations exceeded $19 million during the same period.